首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Evaluating Serious Adverse Drug Reactions
被引:2
|
作者
:
论文数:
引用数:
h-index:
机构:
Somberg, John
[
1
]
论文数:
引用数:
h-index:
机构:
Molnar, Janos
[
2
]
机构
:
[1]
Rush Univ, Dept Med & Clin Pharmacol, Chicago, IL 60612 USA
[2]
Rosalind Franklin Univ Med & Sci, Dept Med, Chicago, IL USA
来源
:
CARDIOLOGY
|
2018年
/ 139卷
/ 03期
关键词
:
D O I
:
10.1159/000486753
中图分类号
:
R5 [内科学];
学科分类号
:
1002 ;
100201 ;
摘要
:
引用
收藏
页码:202 / 202
页数:1
相关论文
共 50 条
[21]
First reports of serious adverse drug reactions in recent weeks
Drugs & Therapy Perspectives,
2007,
23
(7)
: 24
-
25
[22]
First reports of serious adverse drug reactions in recent weeks
Drugs & Therapy Perspectives,
2010,
26
(1)
: 20
-
21
[23]
First reports of serious adverse drug reactions in recent weeks
Drugs & Therapy Perspectives,
2010,
26
(5)
: 20
-
20
[24]
First reports of serious adverse drug reactions in recent weeks
Drugs & Therapy Perspectives,
2012,
28
(4)
: 18
-
18
[25]
First reports of serious adverse drug reactions in recent weeks
Drugs & Therapy Perspectives,
2009,
25
(2)
: 20
-
21
[26]
First reports of serious adverse drug reactions in recent weeks
Drugs & Therapy Perspectives,
2008,
24
(6)
: 21
-
22
[27]
Serious Adverse Drug Reactions in Older Adults Notified to Pharmacovigilance
Charfi, Rim
论文数:
0
引用数:
0
h-index:
0
机构:
Tunisian Natl Ctr Pharmacovigilance, Tunis 1006, Tunisia
Univ Tunis El Manar, Fac Med Tunis, Tunis, Tunisia
Tunisian Natl Ctr Pharmacovigilance, Tunis 1006, Tunisia
Charfi, Rim
El Aidli, Sihem
论文数:
0
引用数:
0
h-index:
0
机构:
Tunisian Natl Ctr Pharmacovigilance, Tunis 1006, Tunisia
Univ Tunis El Manar, Fac Med Tunis, Tunis, Tunisia
Tunisian Natl Ctr Pharmacovigilance, Tunis 1006, Tunisia
El Aidli, Sihem
Zaiem, Ahmed
论文数:
0
引用数:
0
h-index:
0
机构:
Tunisian Natl Ctr Pharmacovigilance, Tunis 1006, Tunisia
Univ Tunis El Manar, Fac Med Tunis, Tunis, Tunisia
Tunisian Natl Ctr Pharmacovigilance, Tunis 1006, Tunisia
Zaiem, Ahmed
Kastalli, Sarah
论文数:
0
引用数:
0
h-index:
0
机构:
Tunisian Natl Ctr Pharmacovigilance, Tunis 1006, Tunisia
Univ Tunis El Manar, Fac Med Tunis, Tunis, Tunisia
Tunisian Natl Ctr Pharmacovigilance, Tunis 1006, Tunisia
Kastalli, Sarah
Srairi, Samia
论文数:
0
引用数:
0
h-index:
0
机构:
Tunisian Natl Ctr Pharmacovigilance, Tunis 1006, Tunisia
Tunisian Natl Ctr Pharmacovigilance, Tunis 1006, Tunisia
Srairi, Samia
Daghfous, Riadh
论文数:
0
引用数:
0
h-index:
0
机构:
Tunisian Natl Ctr Pharmacovigilance, Tunis 1006, Tunisia
Univ Tunis El Manar, Fac Med Tunis, Tunis, Tunisia
Tunisian Natl Ctr Pharmacovigilance, Tunis 1006, Tunisia
Daghfous, Riadh
Lakhal, Mohamed
论文数:
0
引用数:
0
h-index:
0
机构:
Tunisian Natl Ctr Pharmacovigilance, Tunis 1006, Tunisia
Univ Tunis El Manar, Fac Med Tunis, Tunis, Tunisia
Tunisian Natl Ctr Pharmacovigilance, Tunis 1006, Tunisia
Lakhal, Mohamed
THERAPIE,
2012,
67
(05):
: 465
-
470
[28]
First reports of serious adverse drug reactions in recent weeks
Drugs & Therapy Perspectives,
2011,
27
(5)
: 18
-
19
[29]
Oral Antibiotics and the Risk of Serious Cutaneous Adverse Drug Reactions
论文数:
引用数:
h-index:
机构:
Lee, Erika
Gomes, Tara
论文数:
0
引用数:
0
h-index:
0
机构:
Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada
Univ Toronto, Dept Med, Toronto, ON, Canada
Gomes, Tara
Drucker, Aaron
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Toronto, Dept Med, Toronto, ON, Canada
Univ Toronto, Dept Med, Toronto, ON, Canada
Drucker, Aaron
Daneman, Nick
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Toronto, Dept Med, Toronto, ON, Canada
Univ Toronto, Dept Med, Toronto, ON, Canada
Daneman, Nick
Asaf, Ayesha
论文数:
0
引用数:
0
h-index:
0
机构:
ICES, Burnaby, BC, Canada
Univ Toronto, Dept Med, Toronto, ON, Canada
Asaf, Ayesha
Wu, Fangyun
论文数:
0
引用数:
0
h-index:
0
机构:
ICES, Burnaby, BC, Canada
Univ Toronto, Dept Med, Toronto, ON, Canada
Wu, Fangyun
Piguet, Vincent
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Toronto, Dept Med, Toronto, ON, Canada
Univ Toronto, Dept Med, Toronto, ON, Canada
Piguet, Vincent
Juurlink, David
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Toronto, Dept Med, Toronto, ON, Canada
Univ Toronto, Dept Med, Toronto, ON, Canada
Juurlink, David
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY,
2024,
153
(02)
: AB164
-
AB164
[30]
First reports of serious adverse drug reactions in recent weeks
Drugs & Therapy Perspectives,
2005,
21
(9)
: 20
-
21
←
1
2
3
4
5
→